SERPINB1 levels were found decreased in patients with prostate cancer, glioma, and HCC, favoring migration and invasion [75,76,77], while displaying increased expression in cells and patients with oral cancer, correlating with high motility and cell migration in vitro [78]. Here, SERPINB1 is linked to lip and oral cavity carcinoma.